Delivery Order SPE2DB22D3501-SPE2DB25FWR00
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,863.66 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of July 31, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG Inhaler 18GM. The order is a firm fixed-price contract with a ceiling value of $1,029.35 and a completion date of March 28, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,609.68 firm-fixed-price contract is for the delivery of 4,567,104,771 units of the albuterol HFA 90 mcg inhaler with an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This is a $3,850.11 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Albuterol HFA 90mcg inhalers. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM. The contract has a ceiling value of $1,440.00 and a completion date of June 24, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor for this award and holds a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Albuterol HFA 90 MCG inhalers, with a total ceiling value of $8,079.24 and a performance period through March 5, 2025. The contract is a firm fixed-price, delivery order type, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $4,823.43 fixed-price contract is for the supply of 4559091862 - Albuterol HFA 90 MCG inhalers. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.80, is for the delivery of Albuterol HFA 90 MCG inhalers with an ultimate completion date of February 10, 2025. The contract is a firm-fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is also the holder of a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.81, is for the delivery of 4,568,076,535 units of albuterol HFA 90 mcg inhalers, 8.5 grams each. The contract is a firm fixed-price, non-set-aside award with a performance period ending on April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.86 contract is for the delivery of Albuterol HFA 90 MCG Inhaler 18GM, a pharmaceutical product, with a period of performance through July 9, 2025. The contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWR00Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Albuterol HFA 90 MCG Inhalers (8.5 GM) with a ceiling value of $1,373.40. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to complete by July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company maintains an extensive portfolio of federal contracts with DLA covering a wide range of pharmaceutical products and medical supplies for military healthcare programs worldwide. This delivery order represents routine pharmaceutical procurement under AmerisourceBergen's prime vendor agreement, which enables flexible supply of medications, vaccines, medical devices, and specialized healthcare commodities to support military medical operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/30/25 |